Skip to main content
Psychopharmacology Bulletin All Volumes & Issues VOL 53 No. 3 Transcranial Magnetic Stimulation...
REVIEW ARTICLE

Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder—Modus Operandi!

Psychopharmacology Bulletin 53(3) :55-60 , 2023/08/11

Abstract

Background

Transcranial magnetic stimulation (TMS) is effective in the management of treatment resistant major depressive disorder (MDD) and has recently become widely available. Our aim was to explore the literature for evidence of the mechanism of action.

Method

We examined our own accumulating TMS library, the reference lists of all available papers and used a search engine to collect information. We collated and examined this information under relevant heading.

Results

TMS produces a large number of physiological changes including site of stimulation neurochemical, brain wave and blood flow effects, and distant structure effects including neurotransmitter effects and volume increase. TMS also corrects generalized and local functional connectivity (FC) abnormalities which are a feature of MDD.

Conclusion

TMS produces a range of physiological changes. It is unclear which of these underpin its antidepressant. It is likely more than one work synergistically to this end—almost certainly the capacity to correct MDD induced FC abnormalities makes a strong antidepressant contribution.

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Saxby Pridmore, Yvonne Turnier-Shea, Marzena Rybak, Ahmed Naguy. Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder—Modus Operandi!. Psychopharmacology Bulletin. 2023/08/11; 53(3):55-60.